Senior Manager Health Economics, Market Access, Reimbursement (m/f/d)
LivaNova
About this role
Senior Manager for Health Economics, Market Access & Reimbursement (HEMAR) for LivaNova DACH responsible for setting strategic HEMAR priorities across the DACH region with primary focus on Germany. The role covers the full product portfolio including neuromodulation and cardiopulmonary brands, involves collaboration with country commercial leaders, and may include leadership of EU-level initiatives.
Skills
Qualifications
About LivaNova
livanova.comLivaNova is a global medical device company creating neuromodulation devices and cardiopulmonary products to improve the lives of patients worldwide.
Recent company news
Seeking AlphaLivaNova: Excellent Performer, But Too Expensive In 2026 (Rating Downgrade)
2 weeks ago
Business WireLivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance
2 weeks ago
MarketBeatLivaNova PLC (NASDAQ:LIVN) Short Interest Update
1 week ago
Medical Product OutsourcingTouching a Nerve: An Interview with LivaNova CEO Vladimir Makatsaria
1 week ago
Quiver QuantitativeLIVANOVA ($LIVN) Releases Q4 2025 Earnings
2 weeks ago
About LivaNova
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for LivaNova.
Salary
$97k – $132k
per year
More jobs at LivaNova
Similar Jobs
Health Economics & Reimbursement Manager
Medtronic
Director, Health Economics and Market Access, APAC
AtriCure
Director, Health Economics & Reimbursement
Edwards Lifesciences
Senior Manager, Field Health Economics & Reimbursement – Great Plains
Abbott Laboratories
Manager, Global Market Access and Health Economics
Stryker
Director, Health Economics & Reimbursement
Edwards Lifesciences